Evidence map›Paper›PMID 32846024›Full record

ReviewAmerican journal of reproductive immunology (New York, N.Y. : 1989)2021

The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.

Yonghee Song, Youngeun Kim, Sunhyung Ha, Samantha Sheller-Miller, Jaekwang Yoo, Chulhee Choi, Cheol Hyoung Park

Abstract readReview
In one paragraph

Review in American journal of reproductive immunology (New York, N.Y. : 1989), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Exosomes fromInternational journal of molecular sciences · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Clinical Applications of Exosomes: A Critical Review.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yonghee SongILIAS Biologics Inc, Daejeon, Republic of Korea.
Youngeun KimILIAS Biologics Inc, Daejeon, Republic of Korea.
Sunhyung HaILIAS Biologics Inc, Daejeon, Republic of Korea.
Samantha Sheller-MillerDivision of Maternal-Fetal Medicine & Perinatal Research, Department of Obstetrics & Gynecology, The University of Texas Medical Branch, Galveston, TX, USA.
Jaekwang YooILIAS Biologics Inc, Daejeon, Republic of Korea.
Chulhee ChoiILIAS Biologics Inc, Daejeon, Republic of Korea.ORCID 0000-0001-5542-9136
Cheol Hyoung ParkILIAS Biologics Inc, Daejeon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extracellular vesicles (EVs) research area has grown rapidly because of their pivotal roles in intercellular communications and maintaining homeostasis of individual organism. As a subtype of EVs, exosomes are made via unique biogenesis pathway and exhibit disparate functional and phenotypic characteristics. Functionally, exosomes transfer biological messages from donor cell to recipient cell, which makes exosomes as a novel therapeutic platform delivering therapeutic materials to the target tissue/cell. Currently, both academia and industry try to develop exosome platform-based therapeutics for disease management, some of which are already in clinical trials. In this review, we will discuss focusing on therapeutic values of exosomes, recent advances in therapeutic exosome platform development, and late development of exosome therapeutics in diverse therapeutic areas.

Indexed as

AnimalsBiological TherapyCell CommunicationDrug Delivery SystemsExosomesExtracellular VesiclesHumansclinical trialexosomesinflammatory diseasestherapeutic platform

Identifiers

PMID32846024
PMCPMC7900947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.